NCCN's 2026 guidelines recommend routine integration of AI-based 5-year breast cancer risk prediction from mammograms.
Key Details
- 1NCCN updated guidelines to recommend AI-based 5-year breast cancer risk assessment using routine mammograms.
- 2Patients with an AI-predicted 5-year risk ≥1.7% should be considered for supplemental imaging (MRI or ultrasound).
- 3Risk evaluations should begin at age 35, earlier than the previous standard of 40.
- 4Re-assessment over time is advised due to changes in breast tissue.
- 5The Clairity Breast platform, FDA-cleared for this purpose, is highlighted and is reportedly over 3x more accurate at risk prediction than density reporting by radiologists.
Why It Matters
These recommendations will likely accelerate adoption of AI tools in breast imaging, standardizing risk stratification and personalized screening. Radiologists and imaging providers must prepare for new workflows and patient stratification protocols based on AI outputs.
Source
Radiology Business
Related News
•HealthExec
Experts Advocate Licensing Model for Clinical AI Regulation
Three prominent medical leaders propose a six-step licensing pathway to govern autonomous clinical AI, drawing direct parallels to physician licensing.
•AuntMinnie
AI Advances in Breast Cancer Risk, CEUS Training Updates, and Imaging AI Variability
This week's top radiology news reviews AI advances in breast and lung cancer risk prediction, new CEUS training standards, and prostate screening updates with imaging modalities.
•Radiology Business
AMA Urges Caution on AI for Medical Diagnosis and Treatment
The American Medical Association advises against using AI and chatbots as replacements for physician-led diagnosis and treatment decisions.